Adam Mecca
Associate Director, Alzheimer's Disease Research Unit · Yale-New Haven Hospital
Credentials: · · · · ·
History
PresentYale-New Haven Hospital · Yale School of Medicine
- Present
Yale-New Haven Hospital · Yale School of Medicine
- Present
2016–2017- 2012–2016
- 2004–2008
2002–2005
Research
JAMA Neurology · 2018 · 353 citations
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)
American Journal of Physiology-Heart and Circulatory Physiology · 2007 · 305 citations
In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET
Alzheimer s & Dementia · 2020 · First of 16 authors · Corresponding · 242 citations
- CD
49 papers
25 papers · 7 as a fellow
15 papers
- DM
14 papers
8 papers · 4 as a resident
- HB
8 papers · 1 as a resident
7 papers · 3 as a resident
- DD
6 papers
Grants
- 2021–2026
National Institute on Aging · R01
Contact PI · $4.5M · Yale University
- 2018–2022
National Institute on Aging · K23
Contact PI · $977.4K · Yale University
- 2008–2013
Cerebroprotection via Viral-Mediated Gene Delivery of Angiotensin AT2 Receptors
National Institute of Neurological Disorders and Stroke · F30
Contact PI · $140.9K · University of Florida
Clinical trials
- 2023–2025
A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease
Principal investigator · Completed · Phase 1
Allyx Therapeutics
- 2021–2022
Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923
Principal investigator · Completed · Phase 1
Yale University
- 2018–2022
Principal investigator · Completed · Early phase 1
Yale University